Cara Therapeutics, Inc. (CARA) Social Stream
CARA THERAPEUTICS INC (CARA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CARA THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 8 | $35 | $16 | $26.125 | $1.67 | 1464.37% |
| 2021-11-28 | 8 | $35 | $17 | $26.25 | $1.67 | 1471.86% |
| 2022-02-02 | 8 | $35 | $17.001 | $26.25 | $1.67 | 1471.86% |
| 2022-03-02 | 7 | $35 | $15 | $25.875 | $1.67 | 1449.4% |
| 2022-03-08 | 8 | $35 | $15 | $26.25 | $1.67 | 1471.86% |
| 2022-04-06 | 8 | $33 | $15 | $25.428 | $1.67 | 1422.63% |
| 2022-05-09 | 7 | $33 | $15 | $25.428 | $1.67 | 1422.63% |
| 2022-05-16 | 7 | $33 | $13 | $24.571 | $1.67 | 1371.32% |
| 2022-10-10 | 7 | $33 | $13 | $24.714 | $1.67 | 1379.88% |
| 2023-02-09 | 6 | $30 | $13 | $22.333 | $1.67 | 1237.31% |
| 2023-02-16 | 6 | $28 | $13 | $21.5 | $1.67 | 1187.43% |
| 2023-03-07 | 6 | $28 | $18 | $22 | $1.67 | 1217.37% |
| 2023-03-27 | 7 | $28 | $6 | $18 | $1.67 | 977.84% |
| 2023-05-15 | 8 | $28 | $6 | $18.5 | $1.67 | 1007.78% |
| 2023-07-17 | 8 | $28 | $4 | $17.625 | $1.67 | 955.39% |
| 2023-08-07 | 8 | $25 | $4 | $17.25 | $1.67 | 932.93% |
| 2023-08-08 | 8 | $25 | $3.5 | $17.062 | $1.67 | 921.68% |
| 2023-08-09 | 8 | $25 | $3.5 | $16.812 | $1.67 | 906.71% |
| 2023-08-25 | 8 | $25 | $3 | $16.75 | $1.67 | 902.99% |
| 2023-09-07 | 8 | $25 | $3 | $15.5 | $1.67 | 828.14% |
The Trend in the Analyst Price Target
CARA's average price target has moved down $6 over the prior 29 weeks.
CARA reports an average of 292.01% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-08 | 6 | 30 | 13 | 22.333 | 9.51 | 134.84% |
| 2023-02-09 | 6 | 30 | 13 | 22.333 | 11.36 | 96.59% |
| 2023-02-16 | 6 | 28 | 13 | 21.500 | 10.40 | 106.73% |
| 2023-04-17 | 8 | 28 | 6 | 18.500 | 4.43 | 317.61% |
| 2023-06-27 | 8 | 28 | 4 | 17.625 | 3.47 | 407.93% |
CARA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 6 | 1 | 0 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
Over the past 19 months, CARA's average broker recommendation rating improved by 0.21.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, CARA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 2622.4% of them.
- CARA has a greater number of analysts covering the stock than 2300.03% of stocks in the small market cap category.
- CARA THERAPEUTICS INC's variance in analysts' estimates is lower than -2012.13% of stocks in the small market cap category.
- CARA has a higher average analyst price target than 1027.4% of Healthcare stocks.
In the Pharmaceutical Products industry, OCUL, ARDX, and ARCT are the three stocks most similar to CARA THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is CARA a Buy, Hold or Sell? See the POWR Ratings now!